Loading...
Loading...
Browse all stories on DeepNewz
VisitScientists Develop Drugs, Including mTOR Inhibitor Rapamycin, to Extend Lifespan of Dogs with Implications for Human Longevity
Dec 27, 2024, 05:42 AM
Researchers are exploring new drugs aimed at extending the lifespan of dogs, which may have implications for human longevity. Current studies focus on the development of a pill that could prolong the lives of dogs, with scientists suggesting that similar effects might be applicable to humans. This follows the previous identification of the mTOR inhibitor, Rapamycin, as the only molecule rigorously proven to increase lifespan in healthy mice across various studies. The ongoing research into canine longevity could pave the way for advancements in human health and lifespan extension.
View original story
Markets
Yes • 50%
No • 50%
Official announcements from the research team or published results in scientific journals
No • 50%
Yes • 50%
Publication in a reputable scientific journal
No • 50%
Yes • 50%
Clinical trial registries or official announcements by research institutions
Proven effective with significant lifespan extension • 25%
Negative effects or halted trials • 25%
No significant effect on lifespan • 25%
Proven effective with moderate lifespan extension • 25%
Official trial results or publications in scientific journals
Largely indifferent • 25%
Widely accepted and positive • 25%
Cautiously optimistic • 25%
Skeptical or negative • 25%
Surveys or studies published by market research firms or academic institutions
Approved for veterinary use • 25%
Approved for limited use or specific conditions • 25%
Not approved • 25%
Still under review • 25%
Announcements from regulatory bodies such as the FDA or equivalent organizations